Further re Transfer of Assets, Circassia Group Plc, 2020-05-27
27 May 2020
Circassia Group plc
Further re Proposed Transfer of Assets
Circassia Group plc (“Circassia” or “the Company”) today announces that the mandatory 30 day waiting period for US anti-trust clearance expired at midnight on 26 May. Accordingly, the proposed transfer of the Tudorza and Duaklir assets to AstraZeneca first announced on 9 April 2020 is now expected to complete during the course of the next three days.
A further announcement will be made once completion has taken place.
-Ends-
For further information, please contact:
Circassia Group plc
Ian Johnson, Executive Chairman |
c/o Peel Hunt |
Michael Roller, CFO |
|
|
|
Peel Hunt (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 7418 8900 |
James Steel / Oliver Jackson |
|
|
|
finnCap (Joint Broker) | Tel: +44 (0) 20 7220 0500 |
Geoff Nash / Alice Lane |
|
|
|
Numis Securities (Joint Broker) | Tel: +44 (0) 20 7260 1000 |
James Black / Duncan Monteith |
|
END
DISPPUWPAUPUPGQ
Leave a Reply